Overview

Description

  • Nature
    Synthetic
  • Amino Acid Sequence

    Associated products

    Specifications

    Our Abpromise guarantee covers the use of ab193608 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    • Applications

      Blocking - Blocking peptide for Anti-Cripto1 antibody [EPNCI106B] (ab133236)

    • Form
      Liquid
    • Additional notes

      This is the blocking peptide for ab133236

      - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
      - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
      - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
      - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
      - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

    • Concentration information loading...

    Preparation and Storage

    • Stability and Storage

      Shipped at 4°C. Store at -20°C.

    General Info

    • Alternative names
      • CR
      • CRGF
      • cripto
      • Cripto 1
      • Cripto 1 growth factor
      • Cripto-1 growth factor
      • Cripto1 growth factor
      • Epidermal growth factor like cripto protein CR1
      • Epidermal growth factor-like cripto protein CR1
      • TDGF 1
      • TDGF1
      • TDGF1_HUMAN
      • Teratocarcinoma derived growth factor 1
      • Teratocarcinoma-derived growth factor 1
      see all
    • Function
      Could play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm.
    • Tissue specificity
      Preferentially expressed in gastric and colorectal carcinomas than in their normal counterparts.
    • Sequence similarities
      Contains 1 EGF-like domain.
    • Cellular localization
      Cell membrane.
    • Information by UniProt

    References

    ab193608 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab193608.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up